All odd numbered posters will be presented on Friday, November 8, 2019, while even numbered posters will be presented on Saturday, November 9, 2019.
Posters will be on display from 7 a.m. - 8 p.m., with the presenting authors required to be at their posters during lunch (12:30 - 2 p.m. on Friday, Nov. 8, and 12:35 - 2:05 p.m. on Saturday, Nov. 9) and also during the poster reception (6:30 - 8p.m. on Friday, Nov. 8, and 7 - 8:30 p.m. on Saturday, Nov. 9).
|P803||CUE-101, a novel HPV16 E7:pMHC:IL-2:Fc fusion protein, enhances tumor antigen specific T cell activation for the treatment of HPV16-driven malignancies||Steven N. Quayle, PhD; Natasha Girgis, PhD; Dharma Raj Thapa; Zohra Merazga, M.S.; Miguel Moreta; Sandrine Hulot, PhD; Alyssa Nelson, BS.; Lauren Kraemer, BS.; Dominic Beal, PhD; Mark Haydock, BS.; Luke Witt, BS.; Jessica Ryabin, BS.; Jonathan Soriano, MSc; Emily Spaulding, PhD; John F. Ross, PhD; Rodolfo Chaparro, PhD; Ronald Seidel, PhD; Anish Suri, PhD; Saso Cemerski; Kenneth J. Pienta, MD; Mary C. Simcox, PhD;||Novel Single-Agent Immunotherapies||Costimulation; Cytokine; T cell; Vaccine|